Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trial

The AKT inhibitor MK2206 (M) was evaluated in I-SPY 2 and graduated in the HER2+, HR−, and HR− HER2+ signatures. We hypothesized that AKT signaling axis proteins/genes may specifically predict response to M and tested 26 phospho-proteins and 10 genes involved in AKT-mTOR-HER signaling; in addition,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Denise M., Yau, Christina, Wulfkuhle, Julia, Brown-Swigart, Lamorna, Gallagher, Rosa I., Magbanua, Mark Jesus M., O’Grady, Nick, Hirst, Gillian, Asare, Smita, Tripathy, Debu, Berry, Don, Esserman, Laura, Chien, A. Jo, Petricoin, Emanuel F., van ‘t Veer, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532145/
https://www.ncbi.nlm.nih.gov/pubmed/33083527
http://dx.doi.org/10.1038/s41523-020-00189-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532145/
https://www.ncbi.nlm.nih.gov/pubmed/33083527
http://dx.doi.org/10.1038/s41523-020-00189-2

Ejemplares similares